Basic Information
Basic information for C21orf62-AS1-212-20aa-1
Peptide Name C21orf62-AS1-212-20aa-1
Genome Position chr21:32772206-32772265[+]
Species Human
Peptide Sequence MREEEEGRGQREKRLSGRKV
Peptide Length 20
Unique No (C21orf62-AS1-201-20aa-2,C21orf62-AS1-202-20aa-1,C21orf62-AS1-203-20aa-1,C21orf62-AS1-204-20aa-1,C21orf62-AS1-205-20aa-1,C21orf62-AS1-206-20aa-2,C21orf62-AS1-207-20aa-2,C21orf62-AS1-208-20aa-2,C21orf62-AS1-209-20aa-5,C21orf62-AS1-210-20aa-1)
Grand Average of Hydropathicity -2.17
Relative Molecular Mass 2773.01
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000666106;C21orf62-AS1-212
Transcript Length 1651
Coding Ability 0.639
DNA Sequence Corresponding to Peptide ATGAGGGAGGAGGAGGAGGGGAGAGGCCAGAGAGAGAAGCGGCTTTCGGGAAGGAAAGTG
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :